BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16050430)

  • 1. A survey of Australian and New Zealand old age psychiatrists' preferred medications to treat behavioral and psychological symptoms of dementia (BPSD).
    Greve M; O'Connor D
    Int Psychogeriatr; 2005 Jun; 17(2):195-205. PubMed ID: 16050430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert opinion on the management of behavioural and psychological symptoms of dementia (BPSD) and investigation into prescribing practices in the UK.
    Bishara D; Taylor D; Howard RJ; Abdel-Tawab R
    Int J Geriatr Psychiatry; 2009 Sep; 24(9):944-54. PubMed ID: 19156700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical variables influencing treatment decisions for agitated dementia patients: survey of physician judgments.
    Colenda CC; Rapp SR; Leist JC; Poses RM
    J Am Geriatr Soc; 1996 Nov; 44(11):1375-9. PubMed ID: 8909356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotics for BPSD: an audit of prescribing practice in a specialist psychiatric inpatient unit.
    Haw C; Stubbs J; Yorston G
    Int Psychogeriatr; 2008 Aug; 20(4):790-9. PubMed ID: 18307825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged use of antipsychotic medications in long-term aged care in Australia: a snapshot from the HALT project.
    Harrison F; Cations M; Jessop T; Aerts L; Chenoweth L; Shell A; Sachdev P; Hilmer S; Draper B; Brodaty H
    Int Psychogeriatr; 2020 Mar; 32(3):335-345. PubMed ID: 31969207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological treatment of behavioral symptoms in dementia patients].
    Gabryelewicz T
    Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Antipsychotics in Patients with Behavioral and Psychological Symptoms of Dementia: Results of a Spanish Delphi Consensus.
    Manzano-Palomo S; Agüera-Ortiz LF; García-Caballero A; Martínez-Raga J; Ojea-Ortega T; Sánchez-Valle R; Antón-Jiménez M; Monge-Argilés JA; Ramos-García I
    Dement Geriatr Cogn Disord; 2020; 49(6):573-582. PubMed ID: 33176326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
    Zaudig M
    Drug Saf; 2000 Sep; 23(3):183-95. PubMed ID: 11005702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Behavioral and Psychological Symptoms of Dementia.
    Bessey LJ; Walaszek A
    Curr Psychiatry Rep; 2019 Jul; 21(8):66. PubMed ID: 31264056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label use of atypical antipsychotic medications in Canterbury, New Zealand.
    Monasterio E; McKean A
    N Z Med J; 2011 Jun; 124(1336):24-9. PubMed ID: 21946741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for the metabolic syndrome in Australia: a national survey of psychiatrists' attitudes and reported practice in patients prescribed antipsychotic drugs.
    Laugharne J; Waterreus AJ; Castle DJ; Dragovic M
    Australas Psychiatry; 2016 Feb; 24(1):62-6. PubMed ID: 26635377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].
    Pinheiro D
    Encephale; 2008 Sep; 34(4):409-15. PubMed ID: 18922244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing of psychotropic medication for nursing home residents with dementia: a general practitioner survey.
    Cousins JM; Bereznicki LR; Cooling NB; Peterson GM
    Clin Interv Aging; 2017; 12():1573-1578. PubMed ID: 29042758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and misuse of antipsychotic drugs in patients with dementia in Alzheimer special care units.
    Nobili A; Pasina L; Trevisan S; Riva E; Lucca U; Tettamanti M; Matucci M; Tarantola M
    Int Clin Psychopharmacol; 2009 Mar; 24(2):97-104. PubMed ID: 21456106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic therapies of BPSD: messages from psychiatrists].
    Hashimoto M
    Rinsho Shinkeigaku; 2011 Nov; 51(11):857-60. PubMed ID: 22277392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term care center interdisciplinary education program for antipsychotic use in dementia: program update five years later.
    Vida S; Monette J; Wilchesky M; Monette M; Friedman R; Nguyen A; Dastoor D; Cristache G; Sourial N; Tremblay L; Gore B
    Int Psychogeriatr; 2012 Apr; 24(4):599-605. PubMed ID: 22126992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.